topamax

ApprovedSmall molecule

Teva

topamax is one of 120 small molecule programs targeting Total Joint Arthroplasty. It is currently in Approved.

Indications

Total Trials

Active Trials

119

Competitors

Pipeline

Status by Indication[3][1]

Indication

Total Joint ArthroplastyActive, not recruiting

HematomaActive, not recruiting

Cocaine DependenceActive, not recruiting

EpilepsyActive, not recruiting

Total Joint ArthroplastyPhase 1

Active, not recruiting

HematomaApproved

Active, not recruiting

Cocaine DependencePreclinical

Active, not recruiting

EpilepsyApproved

Active, not recruiting

Competition

Competitive Landscape

221 competitors in Epilepsy

#DrugCompanyPhaseTrials

Briviact

UCB

Phase 3

14 2

Epidiolex

Jazz Pharmaceuticals

Phase 3

9 3

Dayvigo

Eisai

Phase 3

1 4

Depacon

AbbVie

Phase 3

1 5

topamax

Teva

Approved

1 6

Actemra

Roche

Phase 3

—7

Deltavit

HHyundai Pharmaceutical Co., LTD.

Phase 3

3 8

Narcan

SScienture

Phase 3

1 9

GWP42003-P

Jazz Pharmaceuticals

Phase 3

1 10

Immunoglobulin

Sanofi

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Fasting Conditions3 trials

Topiramate 25 mg Tablets Under Fasting Conditions

Completed· Teva logo

Teva·Phase 1·NCT00905606·30 enrolled

Topiramate 25 mg Capsules Under Fasting Conditions

Completed· Teva logo

Teva·Phase 1·NCT00905164·24 enrolled

Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting Conditions

Completed· Teva logo

Teva·Phase 1·NCT00905346·24 enrolled

Interaction1 trial

A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate

Completed·BBial - Portela C S.A.·Phase 1·NCT02283814·32 enrolled

Total Joint Arthroplasty1 trial

Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty

Withdrawn·SStanford University·Phase 1·NCT04613024

Headache1 trial

Peripheral Nerve Block and Topiramate in the Treatment of Medication Overuse Headaches

Completed·—·N/A·NCT03767062·90 enrolled

Hematoma1 trial

Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas

Unknown status·UUniversité de Sherbrooke·Phase 4·NCT04759196·56 enrolled

3 more indications

Epilepsy1 trial

Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic Epilepsy

Completed· Johnson & Johnson logo

Johnson & Johnson·Phase 4·NCT00216567·114 enrolled

Fed1 trial

Topiramate 25 mg Capsules Under Fed Conditions

Completed· Teva logo

Teva·Phase 1·NCT00904943·18 enrolled

Cocaine Dependence1 trial

The Effects of Pharmacotherapy on Brain Mechanisms Underlying Cocaine Dependence.

Suspended·HHadassah Medical Organization·N/A·NCT00396734·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 10 trial records for topamax. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — topamax compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for topamax. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Teva company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: Teva

topamax

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Fasting Conditions3 trials

Interaction1 trial

Total Joint Arthroplasty1 trial

Headache1 trial

Hematoma1 trial

Epilepsy1 trial

Fed1 trial

Cocaine Dependence1 trial

References

Drug Info

Quick Facts

Related News